Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
Indoles | 2 | 2021 | 1243 | 0.93 | Why? |
Lopinavir | 4 | 2021 | 4308 | 0.92 | Why? |
Ritonavir | 4 | 2021 | 4212 | 0.90 | Why? |
Hepatitis B Core Antigens | 1 | 2017 | 76 | 0.69 | Why? |
Hepatitis B, Chronic | 1 | 2017 | 616 | 0.42 | Why? |
Chloroquine | 2 | 2020 | 3152 | 0.36 | Why? |
Hepatitis B e Antigens | 2 | 2017 | 99 | 0.34 | Why? |
Liver | 1 | 2017 | 4007 | 0.25 | Why? |
Thymidine | 2 | 2017 | 21 | 0.22 | Why? |
Organophosphonates | 2 | 2017 | 85 | 0.20 | Why? |
Guanine | 2 | 2017 | 146 | 0.19 | Why? |
Lamivudine | 2 | 2017 | 210 | 0.19 | Why? |
vif Gene Products, Human Immunodeficiency Virus | 1 | 2017 | 16 | 0.18 | Why? |
Hepacivirus | 2 | 2018 | 1509 | 0.18 | Why? |
APOBEC-3G Deaminase | 1 | 2017 | 33 | 0.18 | Why? |
Lipid Droplets | 1 | 2018 | 75 | 0.18 | Why? |
Phobic Disorders | 1 | 2020 | 157 | 0.17 | Why? |
Hepatitis B | 2 | 2017 | 888 | 0.17 | Why? |
Adenine | 2 | 2017 | 463 | 0.17 | Why? |
Antiviral Agents | 4 | 2020 | 41703 | 0.17 | Why? |
Anal Canal | 1 | 2020 | 367 | 0.17 | Why? |
Virus Release | 1 | 2018 | 253 | 0.16 | Why? |
Stress, Psychological | 1 | 2020 | 10231 | 0.16 | Why? |
Proteasome Endopeptidase Complex | 1 | 2017 | 249 | 0.16 | Why? |
Plant Preparations | 1 | 2020 | 276 | 0.16 | Why? |
Drug Therapy, Combination | 2 | 2020 | 7268 | 0.15 | Why? |
Nucleotides | 1 | 2018 | 212 | 0.15 | Why? |
5' Untranslated Regions | 1 | 2018 | 375 | 0.14 | Why? |
Virus Assembly | 1 | 2018 | 438 | 0.14 | Why? |
Nucleosides | 1 | 2017 | 221 | 0.14 | Why? |
Carrier Proteins | 1 | 2018 | 513 | 0.14 | Why? |
RNA Helicases | 1 | 2017 | 413 | 0.14 | Why? |
Amino Acids | 1 | 2018 | 552 | 0.13 | Why? |
Nose | 1 | 2020 | 1093 | 0.13 | Why? |
Drug Combinations | 2 | 2020 | 3852 | 0.13 | Why? |
Phytotherapy | 1 | 2020 | 743 | 0.12 | Why? |
Administration, Oral | 1 | 2020 | 2340 | 0.12 | Why? |
Pharynx | 1 | 2020 | 1544 | 0.12 | Why? |
Pneumonia, Viral | 7 | 2020 | 243684 | 0.11 | Why? |
Coronavirus Infections | 7 | 2020 | 253789 | 0.11 | Why? |
Viral Nonstructural Proteins | 2 | 2018 | 4810 | 0.10 | Why? |
Immunohistochemistry | 1 | 2017 | 2275 | 0.10 | Why? |
Feces | 2 | 2020 | 4235 | 0.10 | Why? |
Biopsy | 1 | 2017 | 2811 | 0.09 | Why? |
Adult | 12 | 2021 | 244371 | 0.09 | Why? |
Antibody Formation | 1 | 2021 | 4038 | 0.09 | Why? |
DNA, Viral | 1 | 2017 | 2521 | 0.08 | Why? |
Virus Shedding | 2 | 2020 | 5834 | 0.08 | Why? |
Hepatitis C | 1 | 2018 | 1514 | 0.08 | Why? |
Middle Aged | 11 | 2021 | 270681 | 0.08 | Why? |
Betacoronavirus | 6 | 2020 | 204454 | 0.07 | Why? |
Male | 12 | 2021 | 367725 | 0.07 | Why? |
Female | 12 | 2021 | 380317 | 0.07 | Why? |
Virus Replication | 3 | 2018 | 14331 | 0.06 | Why? |
Aged | 8 | 2021 | 215776 | 0.06 | Why? |
Retrospective Studies | 5 | 2020 | 105322 | 0.06 | Why? |
Humans | 17 | 2021 | 930598 | 0.05 | Why? |
Pandemics | 6 | 2020 | 389249 | 0.05 | Why? |
Viral Proteins | 1 | 2018 | 7370 | 0.05 | Why? |
Cohort Studies | 2 | 2020 | 36005 | 0.05 | Why? |
Prothrombin Time | 1 | 2021 | 434 | 0.05 | Why? |
Viral Load | 1 | 2020 | 15850 | 0.05 | Why? |
Aged, 80 and over | 4 | 2021 | 88759 | 0.05 | Why? |
Cell Line, Transformed | 1 | 2017 | 87 | 0.05 | Why? |
Adolescent | 4 | 2021 | 86841 | 0.04 | Why? |
Medical Records | 1 | 2020 | 513 | 0.04 | Why? |
Hospitalization | 4 | 2021 | 54280 | 0.04 | Why? |
Young Adult | 4 | 2021 | 93724 | 0.04 | Why? |
Tomography, X-Ray Computed | 2 | 2020 | 25144 | 0.04 | Why? |
China | 2 | 2020 | 50654 | 0.04 | Why? |
Intracellular Signaling Peptides and Proteins | 1 | 2018 | 334 | 0.04 | Why? |
Influenza A Virus, H7N9 Subtype | 1 | 2020 | 415 | 0.04 | Why? |
Influenza, Human | 1 | 2020 | 10779 | 0.04 | Why? |
Ubiquitin | 1 | 2017 | 243 | 0.04 | Why? |
Depression | 1 | 2020 | 14116 | 0.04 | Why? |
DNA Mutational Analysis | 1 | 2018 | 581 | 0.04 | Why? |
Prospective Studies | 1 | 2020 | 43301 | 0.04 | Why? |
Hepatocytes | 1 | 2018 | 549 | 0.03 | Why? |
Treatment Outcome | 2 | 2020 | 51732 | 0.03 | Why? |
C-Reactive Protein | 2 | 2021 | 7972 | 0.03 | Why? |
Molecular Sequence Data | 1 | 2018 | 3198 | 0.03 | Why? |
RNA, Viral | 1 | 2020 | 32276 | 0.03 | Why? |
Mutation, Missense | 1 | 2018 | 863 | 0.03 | Why? |
Surveys and Questionnaires | 1 | 2020 | 43792 | 0.03 | Why? |
Cross-Sectional Studies | 1 | 2020 | 53120 | 0.03 | Why? |
Cell Line | 2 | 2018 | 12040 | 0.03 | Why? |
Sequence Alignment | 1 | 2018 | 2109 | 0.03 | Why? |
Disease Progression | 2 | 2021 | 13580 | 0.03 | Why? |
HIV Infections | 1 | 2017 | 11620 | 0.03 | Why? |
Alanine Transaminase | 1 | 2017 | 1329 | 0.03 | Why? |
Combined Modality Therapy | 1 | 2020 | 3395 | 0.03 | Why? |
Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.03 | Why? |
ROC Curve | 1 | 2021 | 6024 | 0.02 | Why? |
Odds Ratio | 1 | 2020 | 5861 | 0.02 | Why? |
Antibodies, Viral | 1 | 2021 | 51949 | 0.02 | Why? |
Medicine, Chinese Traditional | 1 | 2020 | 2255 | 0.02 | Why? |
Respiratory System | 1 | 2020 | 3213 | 0.02 | Why? |
Oxygen | 1 | 2021 | 3715 | 0.02 | Why? |
Hepatitis B virus | 1 | 2014 | 882 | 0.02 | Why? |
Child, Preschool | 2 | 2021 | 36283 | 0.02 | Why? |
Amino Acid Sequence | 1 | 2018 | 6049 | 0.02 | Why? |
Multivariate Analysis | 1 | 2017 | 5440 | 0.02 | Why? |
Logistic Models | 1 | 2021 | 9089 | 0.02 | Why? |
Influenza A Virus, H1N1 Subtype | 1 | 2020 | 2984 | 0.02 | Why? |
Genotype | 1 | 2018 | 4697 | 0.02 | Why? |
Infant | 2 | 2021 | 30274 | 0.02 | Why? |
Proportional Hazards Models | 1 | 2017 | 6543 | 0.02 | Why? |
Drugs, Chinese Herbal | 1 | 2020 | 2760 | 0.02 | Why? |
HEK293 Cells | 1 | 2017 | 8394 | 0.02 | Why? |
Mothers | 1 | 2014 | 1624 | 0.02 | Why? |
Fever | 1 | 2020 | 7795 | 0.02 | Why? |
Child | 2 | 2021 | 70012 | 0.01 | Why? |
Risk Factors | 2 | 2020 | 71621 | 0.01 | Why? |
Case-Control Studies | 1 | 2020 | 17671 | 0.01 | Why? |
Signal Transduction | 1 | 2017 | 7207 | 0.01 | Why? |
Sensitivity and Specificity | 1 | 2021 | 22971 | 0.01 | Why? |
Age Factors | 1 | 2021 | 21039 | 0.01 | Why? |
Follow-Up Studies | 1 | 2017 | 17020 | 0.01 | Why? |
Prognosis | 1 | 2021 | 32490 | 0.01 | Why? |
Host-Pathogen Interactions | 1 | 2017 | 11041 | 0.01 | Why? |
Mutation | 1 | 2017 | 12376 | 0.01 | Why? |
Risk Assessment | 1 | 2021 | 25439 | 0.01 | Why? |
Infectious Disease Transmission, Vertical | 1 | 2014 | 5164 | 0.01 | Why? |
Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
Infant, Newborn | 1 | 2014 | 23105 | 0.01 | Why? |
Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
Pregnancy | 1 | 2014 | 23879 | 0.01 | Why? |
Lung | 1 | 2020 | 31049 | 0.01 | Why? |
Time Factors | 1 | 2014 | 31397 | 0.01 | Why? |
Xia's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(129)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(100)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_